Skip to main navigation
Amgen Logo Amgen Logo
  • Main Menu
  • About
    • Overview
    • Amgen History
    • Mission and Values
    • Leadership
    • Amgen Foundation
    • Awards and Accolades
    • Therapy Areas
      • Cardiovascular Metabolic
      • Bone Health
      • Inflammation
      • Oncology
    • How We Operate
      • Overview
      • Corporate Governance
      • Business Ethics and Compliance
      • Policies, Practices and Disclosures
  • Science
    • Overview
    • Research & Development Strategy
      • Overview
      • Human & Disease Biology
      • Novel Targets & Modalities
      • Clinical Trial Optimization
      • AI & Data Science
    • Pipeline
    • Scientific Advisory Boards
    • Biosimilars
    • Clinical Trials
      • Overview
      • About Clinical Trials
      • Amgen Clinical Trials
      • Clinical Trial Diversity and Representation
      • Information for Healthcare Professionals
      • Clinical Trial Transparency, Data Sharing and Disclosure Practices
      • Clinical Out-of-Hours Support program
      • Investigator Sponsored Studies
    • Scientific Community Initiatives   
      • Overview
      • Educational Outreach Program
      • Postdoctoral Fellows Program
      • Scientific Conferences Program
      • Start-Up Network Program
    • Manufacturing
      • Overview
      • Innovation
      • Quality
      • Reliability
  • PRODUCTS
    • Overview
    • Medical Information
    • Counterfeit Drug Statement
    • Safety Data Sheets
    • Global Patient Safety
      • Overview
      • Who We Are
      • Our Commitment
      • What We Do
      • Adverse Event and Product Complaint Reporting
  • Responsibility
    • Overview
    • Annual Sustainability Highlights Report
    • Corporate Sustainability Strategy
    • Healthy Patients & Communities
      • Overview
      • Access to Healthcare
      • Health Equity
      • Community Investment and Amgen Foundation
      • Product Quality
      • Patient Safety
    • Healthy Planet
      • Overview
      • Environmental Sustainability
      • Responsible Sourcing
    • Healthy Amgen
      • Overview
      • Our Workforce
      • Corporate Governance
      • Business Ethics and Compliance
      • Ethical Research and Development
      • Cybersecurity and Data Privacy
    • Reporting and Metrics
      • Overview
      • CDP
      • Archived Reports
  • Stories
    • All Stories
    • Responsibility
    • People and Culture
    • Science and Innovation
    • Patients
    • Leadership
  • Newsroom
  • Partners
  • Investors
  • Careers
  • Amgen Worldwide
    • linkedIn-icon linkedIn-icon
    • twitter-icon twitter-icon
    • youtube-icon youtube-icon
    • facebook-icon
    • instagram-icon instagram-icon
  • All Stories
  • Responsibility
  • People and Culture
  • Science and Innovation
  • Patients
  • Leadership
  • Popular Tags
  • COVID-19
  • Supporting Our Staff
  • Leveraging Our Science
  • Serving Our Communities
  • All Stories
  • Responsibility
  • People and Culture
  • Science and Innovation
  • Patients
  • Leadership
  • Popular Tags
  • COVID-19
  • Supporting Our Staff
  • Leveraging Our Science
  • Serving Our Communities
Amgen Logo Amgen Logo
  • About
    • Overview
    • Amgen History
    • Mission and Values
    • Leadership
    • Amgen Foundation
    • Therapy Areas
    • General Medicine
    • Rare Disease
    • Inflammation
    • Oncology
    • Awards and Accolades
    • How We Operate
    • Corporate Governance
    • Business Ethics and Compliance
    • Policies, Practices and Disclosures
  • Science
    • Overview
    • Research & Development Strategy
    • Human & Disease Biology
    • Novel Targets & Modalities
    • Clinical Trial Optimization
    • AI in Research & Development
    • Pipeline
    • Scientific Advisory Boards
    • Biosimilars
    • Clinical Trials
    • About Clinical Trials
    • Amgen Clinical Trials
    • Clinical Trial Diversity and Representation
    • Information for Healthcare Professionals
    • Clinical Trial Transparency, Data Sharing and Disclosure Practices
    • Clinical Out-of-Hours Support Program
    • Investigator Sponsored Studies
    • Scientific Community Initiatives
    • Educational Outreach Program
    • Postdoctoral Fellows Program
    • Scientific Conferences Program
    • Start-Up Network Program
    • Manufacturing
    • Innovation
    • Quality
    • Reliability
  • PRODUCTS
    • Overview
    • Medical Information
    • Counterfeit Drug Statement
    • Safety Data Sheets
    • Global Patient Safety
    • Who We Are
    • Our Commitment
    • What We Do
    • Adverse Event and Product Complaint Reporting
  • Responsibility
    • Overview
    • Annual Sustainability Highlights Report
    • Corporate Sustainability Strategy
    • Healthy Patients & Communities
    • Access to Healthcare
    • Health Equity
    • Amgen Foundation and Community Investment
    • Product Quality
    • Patient Safety
    • Healthy Planet
    • Environmental Sustainability
    • Responsible Sourcing
    • Healthy Amgen
    • Our Workforce
    • Corporate Governance
    • Business Ethics and Compliance
    • Ethical Research and Development
    • Cybersecurity and Data Privacy
    • Reporting and Metrics
    • CDP
    • Archived Reports
  • Stories
    • All Stories
    • Responsibility
    • People and Culture
    • Science and Innovation
    • Patients
    • Leadership
  • Newsroom
  • Partners
  • Investors
  • Careers

Breadcrumb

  1. Home
  2. Investors
  3. Q3 2024 Amgen Earnings Conference Call

Event Details

  • Investors
    • About
    • Leadership
    • Mission and Values
  • News & Events
    • Press Releases
    • Presentations
    • Events Calendar
    • Annual Meeting
  • Financials
    • SEC Filings
    • Quarterly Earnings
    • Annual Reports
    • Tax Forms
    • Reconciliations
  • Pipeline
  • Stock
    • Stock Information
    • Dividend Information
    • Fundamentals
  • Corporate Sustainability
    • Corporate Governance
    • Responsibility
    • Environment
    • Diversity, Inclusion & Belonging
    • Green Bond
      • Amgen Green Bond Allocation Report
      • Amgen Green Financing Framework 2022
      • Second-party opinion (SPO) on the bond framework
  • Resources
    • FAQs
    • Email Alerts
    • Investor Contacts

Q3 2024 Amgen Earnings Conference Call

Wednesday, 10.30.2024 1:30 PM PDT

Click here for webcast

Supporting Materials

Q3 2024 Earnings Presentation 1.3 MB
AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
Navbar w/ text
  • Investors
    • About
    • Leadership
    • Mission and Values
  • News & Events
    • Press Releases
    • Presentations
    • Events Calendar
    • Annual Meeting
  • Financials
    • SEC Filings
    • Quarterly Earnings
    • Annual Reports
    • Tax Forms
    • Reconciliations
  • Pipeline
  • Stock
    • Stock Information
    • Dividend Information
    • Fundamentals
  • Corporate Sustainability
    • Corporate Governance
    • Responsibility
    • Environment
    • Diversity, Inclusion & Belonging
    • Green Bond
      • Amgen Green Bond Allocation Report
      • Amgen Green Financing Framework 2022
      • Second-party opinion (SPO) on the bond framework
  • Resources
    • FAQs
    • Email Alerts
    • Investor Contacts

Earnings

Show all
Q1 2026
  • Amgen Q1 2026 Earnings Conference Call
  • AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
  • Q1 2026 Earnings Presentation 2.9 MB
ALL RESULTS 

Data as of:

Minimum 15 minutes delayed. Source: LSEG

MORE STOCK
d-amgen-logo m-amgen-logo
Stay Connected With Amgen.
  • linkedIn-icon linkedIn-icon
  • twitter-icon twitter-icon
  • youtube-icon youtube-icon
  • facebook-icon
  • instagram-icon instagram-icon
Contact Us Sitemap Privacy Statement Terms of Use

© 1996-2020 Amgen Inc. All Rights Reserved. /sites/g/files/knoqqb60211/themes/site/nir_pid3019/dist/images/d-amgen-logo.svg